Torrent Pharma: A leading Indian pharmaceutical company with strong brands across chronic therapies.

Why TORRENT PHARMA ?

• 27 brands now generate more than ₹100 crore each, giving Torrent an unusually deep portfolio of blockbuster brands.

• About 74% of revenue comes from branded business, providing better pricing power than a pure generic pharma company.

• Torrent is ranked Number one among Indian pharma companies in both Brazil and Germany, giving it a rare international footprint.

• Around 90% of its India revenue comes from chronic and sub chronic therapies such as cardiac, CNS, diabetes, GI and dermatology.

• The JB Chemicals acquisition adds not just brands but CDMO capabilities and a larger international presence, creating another potential growth engine.

Where we found value ?

Above valuations in the zone 1620–1720 was identified based on below chart. The grey band is where we expect value to emerge in the stock.

Stock made a low of 1770 and this week made a high of 5250. This happened in just 3yrs.

=============================================================

🌐 Website: https://www.valuationmantra.com

📈 Valuation Mantra is a SEBI registered Research Analyst firm focused on long term value investing with emphasis on downside risk protection. We help investors buy NSE200 & NSE500 stocks at low valuations for long term investing.

🔗 All Links: https://nareshbahrain.bio.link

𝕏 Twitter/X: https://x.com/nareshbahrain

🛡️ SEBI Regn: INH000022215 | 🎓 NISM Certified

📊 18+ yrs industry experience

📄 Disclosures: https://www.valuationmantra.com/Disclosures.pdf